Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5451-5500 of 6050 result(s).
CYDY CytoDyn Inc
02/03/2020 9:42:22 AM
It looks like price is being influe
CYDY CytoDyn Inc
02/03/2020 4:57:42 AM
Therefore Leronlimab, a CCR5 antago (2)
CYDY CytoDyn Inc
02/02/2020 10:59:39 AM
Tests with maraviroc show it will w (2)
CYDY CytoDyn Inc
02/01/2020 3:07:30 PM
Leronlimab should easily beat their (1)
CYDY CytoDyn Inc
02/01/2020 8:01:02 AM
Could the fourth be his father-in-l (1)
CYDY CytoDyn Inc
02/01/2020 3:34:51 AM
One leg of the binding is gp120 dep
CYDY CytoDyn Inc
01/31/2020 8:16:57 PM
gp120 and CCR5 are the two keys nee
CYDY CytoDyn Inc
01/31/2020 8:17:19 AM
If they don't retract the bid we ha
CYDY CytoDyn Inc
01/31/2020 8:02:58 AM
and shorter bragged ihub yesterday" (6)
CYDY CytoDyn Inc
01/30/2020 4:14:15 PM
Might be pure dumping or might have
CYDY CytoDyn Inc
01/30/2020 3:36:26 PM
It looks like someone is continuall
CYDY CytoDyn Inc
01/30/2020 1:39:26 AM
AGC should have everything in place (3)
CYDY CytoDyn Inc
01/30/2020 1:28:42 AM
Off the top of my head, ALS drugs I (1)
CYDY CytoDyn Inc
01/30/2020 1:21:17 AM
I would like to thank once again pa
CYDY CytoDyn Inc
01/29/2020 10:08:34 AM
Where is the next major resistance? (10)
CYDY CytoDyn Inc
01/28/2020 8:44:52 AM
I ran across that study on West Nil (1)
CYDY CytoDyn Inc
01/28/2020 3:38:08 AM
I just watched the video. A cup is (3)
CYDY CytoDyn Inc
01/28/2020 1:56:15 AM
"We filed this lawsuit to stop Vyer (3)
CYDY CytoDyn Inc
01/27/2020 5:15:52 PM
Results from 7 patients with merely (3)
CYDY CytoDyn Inc
01/27/2020 4:16:50 AM
I've mentioned it a few times but N
CYDY CytoDyn Inc
01/22/2020 12:18:48 PM
per etrade - A $6.95 commision (or
CYDY CytoDyn Inc
01/22/2020 9:17:42 AM
After rounds of chemotherapy and th
CYDY CytoDyn Inc
01/22/2020 8:27:54 AM
Downregulates programmed death liga (2)
CYDY CytoDyn Inc
01/22/2020 7:34:57 AM
Only patient 2 is monotherapy. Pati (1)
CYDY CytoDyn Inc
01/22/2020 6:31:23 AM
I thought leronlimab might be able (3)
CYDY CytoDyn Inc
01/21/2020 5:33:46 AM
One of the necessary steps to a NAS (4)
CYDY CytoDyn Inc
01/19/2020 2:39:56 AM
It's like a raffle if you're the on (1)
CYDY CytoDyn Inc
01/18/2020 4:01:06 PM
I do know that CTC is though. NK is (2)
CYDY CytoDyn Inc
01/18/2020 6:38:07 AM
Quite a few years ago I had read ab (1)
CYDY CytoDyn Inc
01/18/2020 6:11:31 AM
NK From a quick look at the MOA - P (2)
CYDY CytoDyn Inc
01/18/2020 2:48:09 AM
Anything directly competitive with (1)
CYDY CytoDyn Inc
01/17/2020 12:14:31 PM
Some good information on toxic mark
CYDY CytoDyn Inc
01/17/2020 10:04:54 AM
Our wholesale cost is a fraction of
CYDY CytoDyn Inc
01/17/2020 9:12:49 AM
It looks like they can charge manuf (1)
CYDY CytoDyn Inc
01/17/2020 1:38:01 AM
The most important question that no (3)
CYDY CytoDyn Inc
01/17/2020 12:30:05 AM
Cytodyn cannot charge anything for
CYDY CytoDyn Inc
01/16/2020 11:26:04 AM
Lower price overseas, in some cases (3)
CYDY CytoDyn Inc
01/15/2020 5:35:31 PM
I'm assuming your posting that to p (3)
CYDY CytoDyn Inc
01/15/2020 9:55:40 AM
Too early for CTC results on patien (1)
CYDY CytoDyn Inc
01/15/2020 1:52:34 AM
News shows and particularly morning (2)
CYDY CytoDyn Inc
01/13/2020 8:20:55 AM
$1.34 USD on the Stuttgart Exchange
CYDY CytoDyn Inc
01/13/2020 6:19:07 AM
If the FDA did request the filing f (3)
CYDY CytoDyn Inc
01/13/2020 5:42:33 AM
Breaking it down to very specific i (1)
CYDY CytoDyn Inc
01/13/2020 5:35:28 AM
misiu and trding beat me to it. (1)
CYDY CytoDyn Inc
01/13/2020 1:57:13 AM
I've heard RBNW is the better inves (1)
CYDY CytoDyn Inc
01/12/2020 9:15:32 AM
The point is you proposed, to my k (8)
CYDY CytoDyn Inc
01/12/2020 4:20:07 AM
(4)
CYDY CytoDyn Inc
01/11/2020 5:54:23 PM
That study was done with vicriviroc (2)
CYDY CytoDyn Inc
01/11/2020 6:15:19 AM
You seem to be using a compound int
CYDY CytoDyn Inc
01/11/2020 6:09:26 AM
Your calculation is wrong. APR deno
Go to page:
  • << First
  • < Previous
  • 109
  • 110
  • Next >

Recent Articles

  • Investigation of Class Action Claims for Charter Communications
  • Investigation Announced for Fiserv Investors Over Potential Losses
  • Lantheus Faces Legal Scrutiny: Investor Options Explained
  • Apple's iPhone 17 Launch, Meta Glasses, And AI Partnerships
  • Max Stock Limited Reveals Increased Shareholdings by Director
  • BYOMA's Innovative Blemish Solutions to Empower Skincare Users
  • Unlocking Skyward Innovation: Lockheed Martin's Vectis System
  • Lead Investors in Savara Inc. Pivotal Lawsuit for SEC Violations
  • Nutex Health Faces Serious Legal Challenges: Updates Inside
  • Investigation into Quantum Corporation Investor Claims Alert
  • Tesla Faces Model Y Investigation Amid Growing Industry Dynamics
  • Faruqi & Faruqi Investigates Investor Claims Against SelectQuote
  • Investigating Claims Against Semler Scientific: What You Need to Know
  • Unicycive Therapeutics: Legal Claims Investigation Focus
  • Legal Team Seeks Investors Impacted by Tronox Holdings' Decline
  • Investigation into Replimune Group, Inc: Shareholder Claims
  • Investigation into Flywire Corporation Sparks Investor Interest
  • Investigation Launched for LifeMD Investors Over Claims
  • Investigation Insights into Lockheed Martin’s Potential Shareholder Claims
  • Investigation Launched for PubMatic Investors Amid Claims
  • Understanding the Recently Underperforming Large-Cap Stocks
  • Exploring Digital Innovations at the World Internet Conference
  • Faruqi & Faruqi Investigates Savara's Securities Claims Now
  • Investigation by Faruqi & Faruqi on RxSight Securities Claims
  • Bitcoin Investors Explore XRP Tundra Presale Opportunity
  • Latest Trends in Cryptocurrency: O'Leary's Views and More
  • Important Updates for RxSight, Inc. Investors Facing Losses
  • Last Week's Large-Cap Stock Winners: Insights and Trends
  • Important Class Action for Replimune Group Investors Revealed
  • Honoring Charlie Kirk: A Legacy of Faith and Freedom
  • LiTime's Innovative Battery Solutions Shine in European RV Market
  • Mike Pence Takes on New Role in Academia at George Mason
  • Warren Buffett Shares Key Insights from Charlie Munger on Investing
  • Trump Uses 'Golden Share' Power to Keep US Steel Plant Open
  • Pujiang Innovation Forum: Bridging Global Tech Communities
  • Starbucks Innovates with Protein and Gluten-Free Menu Additions
  • iPhone 17 Makes Unexpected Appearance in Moscow Retailers
  • Reid Hoffman’s Extensive Investments in AI Subscriptions
  • Investing in Education for a Sustainable Peaceful Future
  • Blumenthal Nordrehaug Bhowmik De Blouw LLP Takes Action Against Greenwaste Recycling
  • Soshiro Hoshina Joins Kaiju No. 8 Game: Exciting New Update
  • The $100,000 H-1B Visa Fee: Implications on Tech Giants
  • Teva's Olanzapine LAI Study Highlights Safety and Efficacy
  • AUSTEDO XR: Improving Lives Through Symptom Management
  • Teva's New Olanzapine LAI Offers Long-Term Safety for Schizophrenia
  • Floyd Mayweather Jr. Faces $1.2M Lawsuit From Vegas Auto Gallery
  • Elon Musk Envisions a Future with Robot-Empowered Abundance
  • Reflections on Leadership and Change in America Today
  • A Historic Week of Changes and Challenges in America
  • Freedom Plaza's Vision: A Transformational Affordable Housing Project
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site